Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis

[1]  I. Amit,et al.  Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling , 2015, Cell.

[2]  Géraldine Guasch,et al.  Three cheers for the goblet cell: maintaining homeostasis in mucosal epithelia. , 2015, Trends in molecular medicine.

[3]  E. Kay,et al.  Protective Role for Caspase-11 during Acute Experimental Murine Colitis , 2014, The Journal of Immunology.

[4]  T. Taniguchi,et al.  Apoptotic Caspases Prevent the Induction of Type I Interferons by Mitochondrial DNA , 2014, Cell.

[5]  R. Flavell,et al.  Inflammasomes and intestinal homeostasis: regulating and connecting infection, inflammation and the microbiota. , 2014, International immunology.

[6]  Markus F. Neurath,et al.  Cytokines in inflammatory bowel disease , 2014, Nature Reviews Immunology.

[7]  C. Dinarello,et al.  Interleukin-18 and IL-18 Binding Protein , 2013, Front. Immunol..

[8]  A. Kaser,et al.  Paneth cells as a site of origin for intestinal inflammation , 2013, Nature.

[9]  L. Lopetuso,et al.  Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease , 2013, Front. Immunol..

[10]  C. Dinarello,et al.  Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice , 2013, Gut.

[11]  Rudolf Jaenisch,et al.  One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering , 2013, Cell.

[12]  F. Cominelli,et al.  New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation. , 2012, Cytokine.

[13]  H. Seno,et al.  Colonic epithelial response to injury requires Myd88 signaling in myeloid cells , 2012, Mucosal Immunology.

[14]  Richard A. Flavell,et al.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity , 2012, Nature.

[15]  A. Kaser,et al.  Genetically determined epithelial dysfunction and its consequences for microflora–host interactions , 2011, Cellular and Molecular Life Sciences.

[16]  Fiona Powrie,et al.  Intestinal homeostasis and its breakdown in inflammatory bowel disease , 2011, Nature.

[17]  Richard A. Flavell,et al.  NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis , 2011, Cell.

[18]  A. Aderem,et al.  Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria , 2010, Nature Immunology.

[19]  F. Marincola,et al.  MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18 , 2010, The Journal of experimental medicine.

[20]  Fiona Powrie,et al.  An innately dangerous balancing act: intestinal homeostasis, inflammation, and colitis-associated cancer , 2010, The Journal of experimental medicine.

[21]  N. Beauchemin,et al.  Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. , 2010, Immunity.

[22]  B. Siegmund.  Interleukin-18 in intestinal inflammation: friend and foe? , 2010, Immunity.

[23]  M. Kastan,et al.  The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. , 2010, Immunity.

[24]  J. Whitsett,et al.  SAM pointed domain ETS factor (SPDEF) regulates terminal differentiation and maturation of intestinal goblet cells. , 2010, Experimental cell research.

[25]  Hans Clevers,et al.  The ets-domain transcription factor Spdef promotes maturation of goblet and paneth cells in the intestinal epithelium. , 2009, Gastroenterology.

[26]  E. Alnemri,et al.  Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression1 , 2009, The Journal of Immunology.

[27]  Sarah L. Brown,et al.  A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells , 2008, Nature.

[28]  J. Pearson,et al.  Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn’s disease , 2008, International journal of clinical practice.

[29]  Caixia Ma,et al.  Modulation of Intestinal Goblet Cell Function during Infection by an Attaching and Effacing Bacterial Pathogen , 2007, Infection and Immunity.

[30]  R. Xavier,et al.  Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.

[31]  J. Wehkamp,et al.  Defensins and other antimicrobial peptides in inflammatory bowel disease , 2007, Current opinion in gastroenterology.

[32]  M. Neurath,et al.  High resolution colonoscopy in live mice , 2006, Nature Protocols.

[33]  Shizuo Akira,et al.  Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance , 2006, Nature Medicine.

[34]  H. Zoghbi,et al.  Gfi1 functions downstream of Math1 to control intestinal secretory cell subtype allocation and differentiation. , 2005, Genes & development.

[35]  L. Hooper.  Faculty Opinions recommendation of Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. , 2005 .

[36]  S. Artavanis-Tsakonas,et al.  Notch signals control the fate of immature progenitor cells in the intestine , 2005, Nature.

[37]  Mario Albrecht,et al.  Genetics of Crohn disease, an archetypal inflammatory barrier disease , 2005, Nature Reviews Genetics.

[38]  Andrea Vondracek,et al.  Generation and characterization of mice transgenic for human IL‐18‐binding protein isoform a , 2003, Journal of leukocyte biology.

[39]  S. Akira,et al.  Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice. , 2003, Scandinavian journal of gastroenterology.

[40]  K. Fellermann,et al.  Crohn's disease: a defensin deficiency syndrome? , 2003, European journal of gastroenterology & hepatology.

[41]  F. Martinon,et al.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.

[42]  Nathalie Perreault,et al.  The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. , 2002, Development.

[43]  H. Zoghbi,et al.  Requirement of Math1 for Secretory Cell Lineage Commitment in the Mouse Intestine , 2001, Science.

[44]  S. Deventer,et al.  Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-alpha production in mice. , 2001, Gastroenterology.

[45]  S. Akira,et al.  Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease. , 2001, Gastroenterology.

[46]  G. Fantuzzi,et al.  Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-γ and TNF-α production , 2001 .

[47]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[48]  D. Nicolae,et al.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.

[49]  G. Fantuzzi,et al.  IL-12–induced IFN-γ is dependent on caspase-1 processing of the IL-18 precursor , 1999 .

[50]  A. Fusco,et al.  Bioactive IL-18 expression is up-regulated in Crohn's disease. , 1999, Journal of immunology.

[51]  S. Akira,et al.  Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. , 1999, Journal of immunology.

[52]  T. Born,et al.  Cloning of a Novel Receptor Subunit, AcPL, Required for Interleukin-18 Signaling* , 1998, The Journal of Biological Chemistry.

[53]  C. Janeway,et al.  MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. , 1998, Molecular cell.

[54]  S. Akira,et al.  Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. , 1998, Immunity.

[55]  C. Moskaluk,et al.  IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. , 1998, Journal of immunology.

[56]  S. Akira,et al.  Defective NK cell activity and Th1 response in IL-18-deficient mice. , 1998, Immunity.

[57]  Matthias Mann,et al.  IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation , 1997 .

[58]  M. Ikeda,et al.  Immunohistochemical and immuno-electron-microscopic detection of interferon-γ-inducing factor (”interleukin-18”) in mouse intestinal epithelial cells , 1997, Cell and Tissue Research.

[59]  C. FordAlexander,et al.  ULCERATIVE colitis. , 1997, Journal of the American Medical Association.

[60]  R. Newcombe,et al.  Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. , 1994, Gut.

[61]  D. A. McCormick,et al.  Mucin depletion in inflammatory bowel disease. , 1990, Journal of clinical pathology.

[62]  H. Okamura,et al.  Endotoxin-induced serum factor that stimulates gamma interferon production , 1989, Infection and immunity.

[63]  E. Szigethy,et al.  Inflammatory bowel disease. , 2011, Pediatric clinics of North America.

[64]  G. Trinchieri,et al.  Innate immune mechanisms of colitis and colitis-associated colorectal cancer , 2011, Nature Reviews Immunology.

[65]  Guoxing Wang,et al.  Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis. , 2009, Differentiation; research in biological diversity.

[66]  G. Fantuzzi,et al.  Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[67]  Ryoichiro Kageyama,et al.  Control of endodermal endocrine development by Hes-1 , 2000, Nature Genetics.

[68]  G. Fantuzzi,et al.  IL-12-induced IFN-gamma is dependent on caspase-1 processing of the IL-18 precursor. , 1999, The Journal of clinical investigation.

[69]  G. Fantuzzi,et al.  Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. , 1999, Immunity.

[70]  D B Young,et al.  IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. , 1997, Science.

[71]  R. Colombo,et al.  Differential diagnosis of Crohn's disease of the colon from ulcerative colitis: ultrastructure study with the scanning electron microscope. , 1986, International journal of tissue reactions.

[72]  G PLACITELLI,et al.  [Ulcerative colitis]. , 1958, La Riforma medica.

[73]  J. Derry,et al.  Inflammation and Inflammatory Bowel Disease , 2022 .